- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 55.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 59.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 64.47M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $20.45M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $21.54M |
| Capex | Q1 2026 · Mar 31, 2026 | $262K |
| Capex | Q1 2026 · Mar 31, 2025 | $811K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $39.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $29.46M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $451.82M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $451.52M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $64.6M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $56.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $460.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $472.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $489.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $511.49M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $116.55M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $113.39M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $592.67M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $589.89M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $218.03M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $211.59M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.05B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.06B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $21.82M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $20.89M |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.98M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $16.63M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $6.46M |
| Revenue | Q1 2026 · Mar 31, 2026 | $180.22M |
| Revenue | Q1 2026 · Mar 31, 2025 | $179.02M |